Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Current Drug Targets|May 19, 2015
Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?Apostolos ApostolidisExpert Opinion on Pharmacotherapy|February 4, 2011
Pharmacotherapy for overactive bladder: minimally invasive treatment -- botulinum toxinsApostolos ApostolidisCurrent Opinion in Urology|February 18, 2017
Neurogenic voiding dysfunctionPetros Georgopoulos, Apostolos ApostolidisEuropean Urology Focus|November 19, 2019
Neurourological Management After Failed Intradetrusor OnabotulinumtoxinA InjectionsApostolos Apostolidis, Anne P CameronCurrent Drug Targets|June 23, 2020
Intravesical Botox for Overactive Bladder: How to Minimize Complications and Manage FailuresApostolos Apostolidis, Efstathios Papaefstathiou, Sotirios GatsosNeurourology and Urodynamics|March 15, 2012
What determines whether a patient with LUTS seeks treatment? ICI-RS 2011Apostolos Apostolidis, Cosimo de Nunzio, Andrea TubaroEuropean Urology|January 24, 2006
Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivityApostolos Apostolidis, Prokar Dasgupta, Clare J FowlerBJU International|April 28, 2015
Retrograde transport of radiolabelled botulinum neurotoxin type A to the CNS after intradetrusor injection in ratsDionysia Papagiannopoulou, Lina Vardouli, Fotios Dimitriadis, et al.World Journal of Urology|November 20, 2012
An exploratory, placebo-controlled, dose-response study of the efficacy and safety of onabotulinumtoxinA in spinal cord injury patients with urinary incontinence due to neurogenic detrusor overactivityApostolos Apostolidis, Catherine Thompson, Xiaohong Yan, et al.Pageof 9